Issue 8 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

32

No.

8

March 03, 2006Mar 03, 2006

Free

DOWNLOAD THE PDF

White House Preparing To Nominate Andrew von Eschenbach as FDA Commissioner, Sources Said

FDA Approves Erbitux for Head & Neck Cancer.

Nancy Davidson Elected ASCO President.

NCI Releases List of Cancer Center Core Grant Funding for FY 2005; Univ. of New Mexico is the Newest NCI-Designated Center.

At AAAS Meeting, David Baltimore Comments on Bush Administration Science Policy.

Recent Issues

Volume 52 | Issue 41 - November 06, 2026

Volume 52 | Issue 40 - October 30, 2026

Volume 52 | Issue 39 - October 23, 2026

Volume 52 | Issue 38 - October 16, 2026

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026